Regulatory PathRegulatory requirements compared

Active substance

Clodronate

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
BONEFOS 400MG CAPSULS400 mgCapsule, hard · Oral use60 Tablet ContainerSAR 401.60NCE · PrescriptionBAYER OYWithdrawn by MAH · Not Marketed
BONEFOS 60MG-ML CONC.FOR PARE.INFUSION60 mg/mlconcentrate for solution for injection · Intravenous use5 AmpouleSAR 392.65NCE · PrescriptionBAYER OYWithdrawn by MAH · Not Marketed

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
CLASTEON02245828400 MGCAPSULE · ORALKNIGHT THERAPEUTICS INC.

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
NHS Drug TariffSodium clodronate 400mg capsules£34.9630 capsule1 Oct 2026
NHS Drug TariffSodium clodronate 400mg capsules£139.83120 capsule1 Oct 2026
NHS Drug TariffSodium clodronate 520mg tablets£114.4460 tablet1 Oct 2026
NHS Drug TariffSodium clodronate 800mg tablets£146.4360 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.